The Coherex FlatStent™ EF PFO Migraine Registry
This study has been terminated.
(Lack of enrollment)
First Posted: January 21, 2011
Last Update Posted: June 27, 2017
Information provided by (Responsible Party):
A prospective, single arm, multicenter clinical registry evaluating the change in migraine headaches in migraine with aura patients who undergo patent foramen ovale (PFO) closure with the Coherex FlatStent™ EF PFO Closure System.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||The Coherex PFO Migraine Registry|
Resource links provided by NLM:
Further study details as provided by Coherex Medical:
Primary Outcome Measures:
- EfficacyPercentage of subjects treated with the FlatStent EF who, achieve a clinically significant reduction in migraine or probable migraine headache days at follow-up.
Secondary Outcome Measures:
- Closure efficacyDegree of closure of PFO at follow-up
|Actual Study Start Date:||February 1, 2011|
|Study Completion Date:||June 1, 2012|
|Primary Completion Date:||June 1, 2012 (Final data collection date for primary outcome measure)|
Device: Transcatheter PFO Closure
Transcatheter PFO Closure
Other Name: Coherex FlatStent™ EF PFO Closure System
Contacts and Locations
No Contacts or Locations Provided